Clinical Trials Logo

Clinical Trial Summary

The study is a multi-center, randomized, open, and parallel study. Approximately 958 subjects will be enrolled in 16 sites. The random number table will be adopted to conduct cluster randomization per township hospital/community health service center. Patients will be randomized 1:1 to receive blood pressure management in Internet medical model or Conventional medical model. After follow-ups of 3 months and 6 months, the blood pressure in each group will be observed and compared.


Clinical Trial Description

Protocol Title:A Comparative Study on Internet Medical Models and Conventional Medical Models for the Management of Patients with Hypertension in China Study Indication:Hypertension Number of Site:16sites Study Duration (from the initiation of the first site to the end of the follow-up for the last subject): 12 months Duration of Treatment and Management: 6 months Planned Number of Subjects:958 subjects, 479 in each group(blood pressure management in Internet medical model, Conventional medical model) Internet Medical Model:Using Internet blood pressure management model: home blood pressure self-monitoring + Internet diagnosis + Maintained or adjusted anti-hypertension drug(s) treatment.

Conventional Medical Model:Using Conventional blood pressure management model: home blood pressure monitoring + face-to-face diagnosis in clinic + Maintained or adjusted anti-hypertension drug(s) treatment.

Inclusion Criteria:

1. Male or female, 45 to 75 years old (including 45and 75 years);

2. Two measurements of resting systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90mmHg on different days during screening;

3. Female subjects of child-bearing potential who are willing to adopt one of the following methods for contraception during the study:

- Oral contraceptive, either combined or progestogen alone.

- Injectable progestogen.

- Implants of levonorgestrel.

- Oestrogenic vaginal ring.

- Percutaneous contraceptive patches.

- Intrauterine device or intrauterine system showing that the expected failure rate is less than 1% per year as stated in the product label.

- Double barrier method: condom and an occlusive cap (diaphragm or cervical/vault caps) with a vaginal spermicidal agent (foam/gel/film/cream/suppository).

4. Subjects who can understand and perform home blood pressure monitoring as required by the study;

5. Subjects who voluntarily participate in the study and sign informed consent form.

Exclusion Criteria:

1. Two measurements of resting systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg on different days during screening;

2. Subjects with the history of cerebral stroke within 6 months prior to screening;

3. Subjects with the history of myocardial infarction within 6 months prior to screening;

4. Subjects with the history of heart failure;

5. Subjects with the history of atrial fibrillation;

6. Subjects with the history of coronary artery revascularization;

7. Subjects with other serious diseases, such as tumor;

8. Subjects diagnosed as the secondary hypertension;

9. Subjects with congenital or acquired organic heart disease;

10. Pregnant or lactant subjects;

11. Subjects with severe mental disease;

12. Subjects with abnormal liver and renal function: ALT or AST>2 X upper limit value; Or creatinine > 2X upper limit value

13. Subjects who were previously diagnosed with diabetes that is currently poorly controlled: FBG>10mmol/L;

14. Subjects who are unable to conduct blood pressure self-test;

15. The subject has any other known condition at screening that would compromise subject safety, might affect life expectancy, or making it difficult to successfully manage and follow the subject according to the protocol.

Efficacy Evaluations:

Primary Efficacy Endpoints:

- Blood pressure control rate of subjects in the two groups at Month 6 Secondary Efficacy Endpoints:

- Blood pressure control rate of subjects in the two groups at Month 3

- Blood pressure value of subjects in the two groups at Month 3 and Month 6

- Change of blood pressure of subjects in the two groups at Month 3 and Month 6

- Variability of blood pressure of subjects in the two groups at Month 3 and Month 6

- Treatment compliance of subjects in the two groups at Month 3 and Month 6

- Medical expense of subjects in the two groups at Month 3 and Month 6

- Treatment satisfaction of subjects in the two groups at Month 3 and Month 6 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03527563
Study type Interventional
Source China Cardiovascular Association
Contact yong huo, master
Phone 13901333060
Email drhuoyong@163.com
Status Not yet recruiting
Phase N/A
Start date September 2018
Completion date September 2019

See also
  Status Clinical Trial Phase
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Recruiting NCT03632668 - Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072 Phase 1
Recruiting NCT02699645 - Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Phase 3
Recruiting NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Enrolling by invitation NCT03660631 - Dissemination of the Cardiovascular Risk Service N/A
Recruiting NCT02796313 - Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities N/A
Recruiting NCT03266510 - Inspiratory Muscle Strength Training to Improve Blood Pressure and Physiological Function N/A
Completed NCT00508365 - Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives Phase 1
Completed NCT00382564 - Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease N/A
Not yet recruiting NCT03678207 - The Effectiveness of a Preoperative Blood Pressure Screening Program to Identify Undiagnosed Hypertension in Ambulatory Surgery Patients
Recruiting NCT03249753 - The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects Phase 1
Completed NCT03100812 - Asian American Partnerships in Research and Empowerment (AsPIRE) N/A
Recruiting NCT03099343 - Tailored Messaging to Reduce Sodium Intake N/A
Active, not recruiting NCT03288142 - The Smart Hypertension Control Study N/A
Completed NCT02147626 - Heart Health 4 Moms N/A
Not yet recruiting NCT03661177 - Reclaiming Indigenous Food and Health N/A
Enrolling by invitation NCT03683186 - A Study Evaluating the Long-Term Safety and Efficacy of Ralinepag in Subjects With PAH Via an Open-Label Extension Phase 3
Not yet recruiting NCT03595267 - Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.
Not yet recruiting NCT01620788 - Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment Phase 3
Not yet recruiting NCT03293147 - OUTREACH: Urine Analysis and Antihypertensive Treatment N/A